MX2012006636A - Microcapsulas estabilizadas con nucleo, metodo para su preparacion y usos de las misma. - Google Patents

Microcapsulas estabilizadas con nucleo, metodo para su preparacion y usos de las misma.

Info

Publication number
MX2012006636A
MX2012006636A MX2012006636A MX2012006636A MX2012006636A MX 2012006636 A MX2012006636 A MX 2012006636A MX 2012006636 A MX2012006636 A MX 2012006636A MX 2012006636 A MX2012006636 A MX 2012006636A MX 2012006636 A MX2012006636 A MX 2012006636A
Authority
MX
Mexico
Prior art keywords
preparation
stabilized microcapsules
core
core stabilized
microcapsules
Prior art date
Application number
MX2012006636A
Other languages
English (en)
Other versions
MX344128B (es
Inventor
Ofer Toledano
Hanan Sertchook
Haim Bar-Simantov
Sharon Fireman-Shoresh
Dorit Marco-Dagan
Original Assignee
Sol Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Technologies Ltd filed Critical Sol Gel Technologies Ltd
Publication of MX2012006636A publication Critical patent/MX2012006636A/es
Publication of MX344128B publication Critical patent/MX344128B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención proporciona microcápsulas estabilizadas con núcleo, en donde dicho núcleo comprende al menos un agente activo encapsulado dentro de una carcasa de óxido metálico, procesos para su preparación, composiciones que las comprenden y usos de las mismas.
MX2012006636A 2009-12-31 2010-12-30 Microcapsulas estabilizadas con nucleo, metodo para su preparacion y usos de las mismas. MX344128B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29159409P 2009-12-31 2009-12-31
PCT/IL2010/001092 WO2011080741A2 (en) 2009-12-31 2010-12-30 Core stabilized microcapsules, method of their preparation and uses thereof

Publications (2)

Publication Number Publication Date
MX2012006636A true MX2012006636A (es) 2012-07-10
MX344128B MX344128B (es) 2016-12-06

Family

ID=44226918

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012006636A MX344128B (es) 2009-12-31 2010-12-30 Microcapsulas estabilizadas con nucleo, metodo para su preparacion y usos de las mismas.

Country Status (13)

Country Link
US (2) US10512796B2 (es)
EP (1) EP2467132B1 (es)
JP (1) JP5934107B2 (es)
KR (1) KR20130008002A (es)
CN (1) CN102596186B (es)
AU (1) AU2010337830B2 (es)
BR (1) BR112012012023A2 (es)
CA (1) CA2773544C (es)
EA (1) EA201200347A1 (es)
ES (1) ES2611499T3 (es)
MX (1) MX344128B (es)
WO (1) WO2011080741A2 (es)
ZA (1) ZA201203582B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2732368C (en) 2008-07-31 2017-11-14 Sol-Gel Technologies Ltd. Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof
WO2011080741A2 (en) 2009-12-31 2011-07-07 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
MX363379B (es) 2011-06-29 2019-03-21 Sol Gel Tech Ltd Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta.
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013158410A1 (en) * 2012-04-18 2013-10-24 Rohm And Haas Company Wax-biocide wood treatment
US10806697B2 (en) * 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN102726383B (zh) * 2012-07-05 2015-03-18 常州美胜生物材料有限公司 一种缓释型害虫引诱剂微胶囊及其制备方法
FI126168B (en) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
JP6423355B2 (ja) * 2012-11-27 2018-11-14 ソル − ゲル テクノロジーズ リミテッド 酒さの治療のための組成物
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
CN104624125B (zh) * 2013-11-11 2018-03-02 中国人民银行印制科学技术研究所 一种光致变色双壳微胶囊及其制备方法和应用
CN103908912A (zh) * 2014-03-13 2014-07-09 安徽明讯新材料科技有限公司 一种相变恒温配胶容器
US9480960B2 (en) * 2014-12-01 2016-11-01 National Chung Shan Institute Of Science And Technology Process for preparing phase change microcapsule having thermally conductive shell
EP3294420A1 (en) * 2015-05-13 2018-03-21 Unilever NV Benefit delivery particle and composition comprising the particle
JP6526322B2 (ja) * 2015-08-20 2019-06-05 ソル − ゲル テクノロジーズ リミテッド 過酸化ベンゾイルおよびアダパレンを含む局所投与用組成物
KR101779846B1 (ko) 2015-08-31 2017-10-10 주식회사 티케이케미칼 나노다공성을 갖는 서방성 미분말과 그 제조방법
CN105754554B (zh) * 2016-02-02 2019-02-19 中南林业科技大学 一种含纳米TiO2的纤维素基低温相变储能微胶囊及其制备方法
EP3423030B1 (en) * 2016-03-04 2024-04-24 Arkema, Inc. Encapsulation of peroxides for skin applications
CN105797659B (zh) * 2016-04-08 2018-12-14 东南大学 一种二氧化硅壳聚糖双壳储热微胶囊的制备方法
WO2019012536A1 (en) 2017-07-12 2019-01-17 Sol-Gel Technologies Ltd. METHODS AND COMPOSITIONS FOR TREATING ACNEA
CA3069359C (en) * 2017-07-12 2023-01-10 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
CN107213806B (zh) * 2017-07-13 2018-03-06 广州达济医学科技有限公司 一种用于滤除白细胞的滤膜及其制备方法
US11643584B2 (en) * 2017-11-16 2023-05-09 Georgia Tech Research Corporation Incorporation of microencapsulated phase change materials into wet-spin dry jet polymeric fibers
CN109338135B (zh) * 2018-10-11 2020-07-14 西北工业大学 一种核壳结构Al@Ti-Al2O3相变蓄热复合材料及制备方法
RU2701030C1 (ru) * 2018-12-29 2019-09-24 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Способ получения полых кремнеземных нанокапсул
CA3213930A1 (en) 2019-04-17 2020-10-22 The Procter & Gamble Company Capsules
EP3956054A1 (en) 2019-04-17 2022-02-23 The Procter & Gamble Company Methods of making capsules
JP7395611B2 (ja) 2019-04-17 2023-12-11 ザ プロクター アンド ギャンブル カンパニー カプセル
WO2021006615A1 (ko) * 2019-07-09 2021-01-14 주식회사 엘지생활건강 화장품용 캡슐
WO2021132729A1 (ja) * 2019-12-27 2021-07-01 花王株式会社 マイクロカプセルの製造方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
MX2023004226A (es) 2020-10-16 2023-04-21 Procter & Gamble Composiciones antitranspirantes y desodorantes que comprenden capsulas.
MX2023004227A (es) 2020-10-16 2023-04-21 Procter & Gamble Composiciones liquidas para el cuidado de telas que comprenden capsulas.
CN112143476B (zh) * 2020-10-21 2022-03-04 南京工业大学 一种采用微流场反应技术制备纳米包覆驱油剂的方法及装置
CN116919939A (zh) * 2022-04-02 2023-10-24 南京毓浠医药技术有限公司 一种维a酸和过氧化苯甲酰组合物及其制备方法和用途
US20240018404A1 (en) * 2022-07-13 2024-01-18 King Fahd University Of Petroleum And Minerals Doped phase change material and method of preparation thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906108A (en) 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
GB9021061D0 (en) 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
DE69433131T2 (de) 1993-02-26 2004-07-08 Estee Lauder Inc. Titandioxiddispersionen, kosmetische präparate und verfahren für ihre verwendung
US5401517A (en) 1993-11-15 1995-03-28 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic method for treatment of skin
US5720949A (en) 1996-05-06 1998-02-24 Bristol-Myers Squibb Company Foamable cosmetic mask product
US5891476A (en) 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6337089B1 (en) 1998-02-06 2002-01-08 Seiwa Kasei Company, Limited Microcapsule containing core material and method for producing the same
US6099894A (en) 1998-07-27 2000-08-08 Frisby Technologies, Inc. Gel-coated microcapsules
WO2000009652A2 (en) 1998-08-13 2000-02-24 Sol-Gel Technologies Ltd. Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6238650B1 (en) 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
DE60033279T2 (de) 1999-05-25 2007-11-22 Sol-Gel Technologies Ltd. Ein verfahren zur herstellung von einem lichtstabilen sonnenschutzmittel
WO2001080823A2 (en) * 2000-04-21 2001-11-01 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
BRPI0413131A (pt) 2003-07-31 2007-04-10 Sol Gel Technologies Ltd micro-cápsulas carregadas com ingredientes ativos e um método para sua preparação
DE102004017221A1 (de) 2004-04-05 2005-10-20 Cognis Ip Man Gmbh O/W-Gel-Zusammensetzungen mit Estern des Pentaerythrits oder dessen Oligomeren
WO2005097056A1 (de) 2004-04-05 2005-10-20 Cognis Ip Management Gmbh Wachmischung auf basis von partialglyceriden und pentaerythritestern
WO2007015243A2 (en) * 2005-08-02 2007-02-08 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
WO2007092312A2 (en) 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
EP2104558A2 (en) * 2006-12-12 2009-09-30 Sol-Gel Technologies Ltd. Formation of nanometric core-shell particles having a metal oxide shell
WO2008093346A2 (en) 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
KR100837558B1 (ko) 2007-04-30 2008-06-12 (주)아모레퍼시픽 이중으로 안정된 세라마이드 나노 캡슐 포함 에멀젼조성물, 그의 제조방법 및 이를 이용한 피부 화장료 조성물
WO2008134908A1 (en) 2007-05-08 2008-11-13 Givaudan Sa Wax encapsulation
CA2732368C (en) 2008-07-31 2017-11-14 Sol-Gel Technologies Ltd. Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof
WO2011080741A2 (en) 2009-12-31 2011-07-07 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof

Also Published As

Publication number Publication date
EA201200347A1 (ru) 2012-07-30
JP2013516404A (ja) 2013-05-13
ZA201203582B (en) 2013-01-30
AU2010337830A1 (en) 2012-03-22
AU2010337830B2 (en) 2013-10-03
US20180117369A1 (en) 2018-05-03
CN102596186A (zh) 2012-07-18
CN102596186B (zh) 2017-08-11
EP2467132B1 (en) 2016-10-19
BR112012012023A2 (pt) 2016-05-17
US10512796B2 (en) 2019-12-24
CA2773544C (en) 2019-02-12
WO2011080741A2 (en) 2011-07-07
EP2467132A2 (en) 2012-06-27
ES2611499T3 (es) 2017-05-09
KR20130008002A (ko) 2013-01-21
US20120202695A1 (en) 2012-08-09
MX344128B (es) 2016-12-06
JP5934107B2 (ja) 2016-06-15
CA2773544A1 (en) 2011-07-07
WO2011080741A3 (en) 2011-10-13

Similar Documents

Publication Publication Date Title
MX2012006636A (es) Microcapsulas estabilizadas con nucleo, metodo para su preparacion y usos de las misma.
WO2010013250A3 (en) Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof
MX2014006460A (es) Microcápsulas de sílice, proceso para hacer las mismas y uso de las mismas.
IL220679A (en) Method of manufacture of solid preparations containing basic active pharmaceutical ingredients and the solid preparations produced by the method
MX2021012435A (es) Capsulas.
IN2015KN00664A (es)
UA115531C2 (uk) Каталізатор і спосіб його одержання
TWI371496B (en) Alloy composition, fe-based nanocrystalline alloy and manufacturing method of the same
WO2012085657A3 (en) Tamper resistant solid oral dosage forms
MX357583B (es) Capsulas de nucleo-corteza.
ZA200807778B (en) Reverse-Phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulations WDG-CS, ZC, EC-SC and CX
WO2010079468A3 (en) Delivery particle
PL2329713T3 (pl) Środek do zwalczania chorób roślin zawierający D-tagatozę jako składnik czynny i sposób zwalczania chorób roślin
GB0623748D0 (en) Microcapsules, their use and processes for their manufacture
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
EP2116304A4 (en) PROCESS FOR PRODUCING DOPED TITANIUM OXIDE, DOPED TITANIUM OXIDE AND PHOTOCATALYST RESPONSIBLE FOR VISIBLE LIGHT COMPRISING DOPED TITANIUM OXIDE
PL2329816T3 (pl) Przeciwrakowa substancja czynna z Antrodia camphorata, sposób jej wytwarzania i jej zastosowanie
MX2021012434A (es) Capsulas.
EP3007684B8 (en) A process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell
WO2014058509A3 (en) Casting cores and manufacture methods
EP2611730A4 (en) IRON OXIDE NANOCAPSULES, PROCESS FOR PRODUCING THE SAME, AND MRI CONTRAST AGENT USING SAME
WO2011042902A3 (en) Microcapsules comprising benzoyl peroxide and topical compositions comprising them
GB0622894D0 (en) Microcapsules, their use and processes for their manufacture
MY160372A (en) Composition for improving brain function and method for improving brain function
WO2008019782A3 (de) Dispersionen von nanoharnstoffen. enthaltend wirkstoffe

Legal Events

Date Code Title Description
FG Grant or registration